K-pop

Jewelry’s Seo In-young to Remarry on the 26th of Next Month… “Intimate Wedding at a Church”

The groom-to-be is a businessman six years her senior

KIM HYUNSIK
2026-11-05 08:28:53
[Edaily Reporter KIM HYUNSIK ] Singer Seo In-young (42), formerly of the girl group Jewelry, is set to remarry on the 26th of next month.
Seo In-young (Photo courtesy of SW Entertainment)
Seo In-young revealed this news in a video posted on the 4th to her YouTube channel, “Seo In-young: A New Beginning.”
In the video, Seo In-young said, “We’ll have a small wedding at a church,” adding that members of Jewelry and fellow singer Lynn are scheduled to attend as guests. She also mentioned that she recently purchased an apartment in Namyangju, Gyeonggi Province, and plans to set it up as her new home.
Since her debut as a member of Jewelry in 2002, Seo In-young has gained popularity with songs such as “I Really Like You,” “Super Star,” and “One More Time.” After leaving the group in 2010, she continued her career as a solo artist.
Seo In-young married a non-celebrity businessman in 2023 but divorced the following year. Her new husband is Choi Ji-hoon, CEO of the content creative company NP, who is six years her senior. It was revealed last June that the couple had become engaged, and the wedding date was announced for the first time in this video.

Economy

Corporation

IT·Science

Economy

“We Pay Interest First”… Kbank Deposits Surge by 1.1 Trillion Won in Just One Month

#Kbank’s new fixed-term deposit product, which allows customers to choose when they receive interest, has surpassed 1.1 trillion won in new deposits within just one month. With this product, customers…
2026-11-06 10:41:18

Corporation

Shinsegae Co.,Ltd Appoints Lee Seok-gu as New Head of Department Store Division… “To Enhance Financial Soundness”

Shinsegae Co.,Ltd has appointed Lee Seok-gu, CEO of Shinsegae DF, as the new head of its department store division. Through this appointment, the Shinsegae Department Store Division plans to strengthe…
2026-11-06 11:09:25

IT·Science

Next Year Will Be Decisive for Aptabio Therapeutics Inc.’s New Kidney Drug… CEO Lee Soo-jin: “65% Enrollment in Phase 2b Trial”

Aptabio Therapeutics Inc.(293780)has completed approximately 65% of patient enrollment for the domestic Phase 2b clinical trial of “Isuzinacxib” (APX-115), a treatment for diabetic nephropathy. As it …
2026-11-06 11:02:02